Shanghai Neutan Pharmaceutical Co., Ltd. (Neutan) founded in October 2019, Selected as a national high-tech enterprise,To provide professional one-stop full-process CDMO services for biotechnology companies and traditional pharmaceutical companies.

Neutan takes innovative research and development as the core drive of enterprise development, with senior experts in the industry, such as Dr. Liu Xuejun, Dr. David, Chen, and Dr. Chen Xiaodong as the core. The founding team members are from well-known pharmaceutical enterprises, with an average of more than 20 years of experience in drug research and development and industrialized operation management, Rich experience in new drug development and production

Neutan has advanced R&D equipment, a good working environment, a reasonable talent echelon, and a strong R&D technical force.
Neutan has made great efforts in New Drug Registration Starting Materials, API manufacturing process development and production，Preparation and formulation process development and production，analytical method development，research and development management system , production quality management system, EHS management system, and personnel training, forming its core competitiveness.
Neutan has complete industrial advantages, with R&D centers in Shanghai and Nanjing, and production bases in Hebei, Shandong, Anhui, Zhejiang, etc.

Neutan, facing the global mainstream markets, provides customers with:
CMC Research Services: New Drug Registration Starting Materials, APIs and Formulations
CMO production: cGMP new drug APIs, preparation clinical samples and commercial products

Mission: Help R&D of new drugs and pursue for human health
Aspiration: To become the leading small molecule CDMO service platform in the world